Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Metabolic syndrome, leaky guts, and infection: Metabolic syndrome often accompanies obesity and hyperglycemia and is associated with a breakdown in the integrity of the intestinal barrier and increased risk of systemic infection. Thaiss et al. found that mice with systemic infection of a Salmonella analog, Citrobacter rodentium , also exhibited hyperglycemia. Deletion of the glucose transporter GLUT2 altered sensitivity to chemically induced epithelial permeability and protected mice from pathogen invasion. The authors also found a correlation in humans between glycated hemoglobin (an indicator of hyperglycemia) and serum levels of pathogen recognition receptor ligands. Science , this issue p. 1376
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thaiss et al. clearly showed that hyperglycemia drives intestinal permeability by the glucose transporter GLUT2-dependent transcriptional reprogramming of intestinal epithelial cells, resulting in changes in tight and adherence junction integrity, and a systemic influx of microbial products into portal blood [274].”
From Gut-pancreas-liver Axis as a target for treatment of NAFLD/NASH (2020) · cites this paper as [274]
Citations
Cites
QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887
Heinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y. C., Laslo, P., Cheng, J. X., Murre, C., Singh, H., & Glass, C. K. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.004 · Cited by 13,382
TopHat: discovering splice junctions with RNA-Seq
Trapnell, C., Pachter, L., & Salzberg, S. L. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp120 · Cited by 11,617
DAVID: Database for Annotation, Visualization, and Integrated Discovery
Dennis, G., Sherman, B. T., Hosack, D. A., Yang, J., Gao, W., Lane, H. C., & Lempicki, R. A. (2003) · Genome Biology · doi:10.1186/gb-2003-4-5-p3 · Cited by 9,327
Origin and physiological roles of inflammation
Medzhitov, R. (2008) · Nature · doi:10.1038/nature07201 · Cited by 6,618
Cani, P. D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A. M., Delzenne, N. M., & Burcelin, R. (2008) · Diabetes · doi:10.2337/db07-1403 · Cited by 4,819
Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease
Sampson, T. R., Debelius, J. W., Thron, T., Janssen, S., Shastri, G. G., Ilhan, Z. E., Challis, C., Schretter, C. E., Rocha, S., Gradinaru, V., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.018 · Cited by 3,622
Inflammation, metaflammation and immunometabolic disorders
Hotamisligil, G. S. (2017) · Nature · doi:10.1038/nature21363 · Cited by 2,570
Massively parallel single-cell RNA-seq for marker-free decomposition of tissues into cell types
Jaitin, D. A., Kenigsberg, E., Keren-Shaul, H., Elefant, N., Paul, F., Zaretsky, I., Mildner, A., Cohen, N., Jung, S., Tanay, A., et al. (2014) · Science · doi:10.1126/science.1247651 · Cited by 1,795
Van der Sluis, M., De Koning, B. A. E., De Bruijn, A. C. J. M., Velcich, A., Meijerink, J. P. P., Van Goudoever, J. B., Büller, H. A., Dekker, J., Van Seuningen, I., Renes, I. B., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.04.020 · Cited by 1,684
Cited by
Items 401–500 of 965
Wang, W., Zhang, Y., Wang, X., Che, H., & Zhang, Y. (2021) · Plant Foods for Human Nutrition · doi:10.1007/s11130-021-00919-2 · Cited by 22
Enteroendocrine System and Gut Barrier in Metabolic Disorders
Osinski, C., Moret, D., Clément, K., Serradas, P., & Ribeiro, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073732 · Cited by 22
“Mechanistic studies in rodents have also shown that hyperglycemia per se may increase intestinal barrier permeability through a GLUT2-dependent alteration of tight junction integrity, subsequently causing a leaky gut [138].”
BackgroundSelf-citationCheng, Z., Wang, Y., & Li, B. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c02654 · Cited by 20
Hold the Door: Role of the Gut Barrier in Diabetes
Martin, A., & Devkota, S. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.04.017 · Cited by 20
Yin, Y., Guo, W., Chen, Q. Y., Tang, Z., Liu, Z., Lin, R., Pan, T., Zhan, J., & Ren, L. (2025) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5c00889 · Cited by 23
Intestinal Barrier Dysfunction Participates in the Pathophysiology of Ischemic Stroke
Wei, M., Huang, Q., Liu, Z., Luo, Y., & Xia, J. (2021) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527320666210322115808 · Cited by 20
Morresi, C., Vasarri, M., Bellachioma, L., Ferretti, G., Degl’Innocenti, D., & Bacchetti, T. (2022) · Marine Drugs · doi:10.3390/md20070457 · Cited by 19
“A dysfunctional intestinal barrier is associated also with dysmetabolic diseases, including diabetes and obesity [19,26,27].”
BackgroundGlucose-lowering effects of orally administered superoxide dismutase in type 2 diabetic model rats
Guo, J., Liu, H., Zhao, D., Pan, C., Jin, X., Hu, Y., Gao, X., Rao, P., & Liu, S. (2022) · npj Science of Food · doi:10.1038/s41538-022-00151-5 · Cited by 19
Mitchell, S. B., Hung, Y.-H., Thorn, T. L., Zou, J., Başer, F., Güleç, Ş., Cheung, C., & Aydemir, T. B. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1220533 · Cited by 20
“Intestinal permeability shown to be driven by hyperglycemia (24), suggesting that in response to the sucrose, there were sequences of events starting with hyperglycemia leading to the intestinal permeability.”
BackgroundResultSchellenberg, C., Lagrange, J., Ahmed, M. U., Arnone, D., Campoli, P., Louis, H., Touly, N., Caron, B., Plénat, F., Perrin, J., et al. (2023) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjad198 · Cited by 19
Insulin receptor signaling engages bladder urothelial defenses that limit urinary tract infection
Schwartz, L., Salamon, K., Simoni, A. A., Eichler, T. E., Jackson, A. R., Murtha, M. J., Becknell, B., Kauffman, A., Linn, S. C., Holdsworth, N., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114007 · Cited by 26
Darm-Herz-Achse: Wie Darmbakterien kardiovaskuläre Erkrankungen beeinflussen
Bartolomaeus, H., McParland, V. J., & Wilck, N. (2020) · Herz · doi:10.1007/s00059-020-04897-0 · Cited by 23
Stratmann, J., Lacko, R., Balló, O., Shaid, S., Gleiber, W., Vehreschild, M. J. G. T., Wichelhaus, T. A., Reinheimer, C., Göttig, S., Kempf, V. A. J., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0242544 · Cited by 19
“Diabetes has previously been identified as a potential risk factor for MDRO colonization [36, 37] and subsequent bloodstream infections with intestinal bacteria due to disruption of the gut barrier [38, 39].”
BackgroundWang, Y., Ding, L., Yang, J., Liu, L., & Dong, L. (2021) · PeerJ · doi:10.7717/peerj.10800 · Cited by 19
Crakes, K. R., Pires, J., Quach, N., Ellis-Reis, R. E., Greathouse, R. L., Chittum, K. A., Steiner, J. M., Pesavento, P. A., Marks, S. L., Dandekar, S., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-92966-7 · Cited by 25
Sodium Butyrate Attenuated Diabetes-Induced Intestinal Inflammation by Modulating Gut Microbiota
Liu, L., Chen, Y., Wu, Q. J., Shu, A., & Sun, J. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/4646245 · Cited by 22
“Another study found that hyperglycemia could drive intestinal epithelial barrier function by interfering with intestinal epithelial cells in diabetic mice, contributing to the spread of irritating microbial metabolites throughout the body and enhancing the spread of intestinal infections [32].”
BackgroundThe Role of the Adrenal–Gut–Brain Axis on Comorbid Depressive Disorder Development in Diabetes
Mázala-de-Oliveira, T., da Silva, B. P. B., Campello‐Costa, P., & Carvalho, V. F. (2023) · Biomolecules · doi:10.3390/biom13101504 · Cited by 20
“In diabetic patients, hyperglycemia and low-grade inflammation are capable of disrupting the BBB, especially in the hippocampus region, and the epithelial–intestinal barrier [136–139].”
BackgroundRole of pattern recognition receptors and microbiota-derived ligands in obesity
Rolland, A., Douard, V., & Lapaque, N. (2024) · Frontiers in Microbiomes · doi:10.3389/frmbi.2024.1324476 · Cited by 19
“…protein kinase (AMPK) pathways, more ef fi cient caloric extraction from complex carbohydrates, effects on intestinal motility and secretion of intestinal hormones (Backhed et al., 2004, 2007; Cani et al., 2008, 2009; Turnbaugh and Gordon, 2009; Turnbaugh et al., 2009; Thaiss et al., 2018).”
Ye, M., Liu, Y., Wang, F., Yang, X., Yang, X.-B., Gao, X., Liu, W., & Yu, J. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.132121 · Cited by 18
Liu, L., Yang, T., Wang, S., Jia, W., Liu, Y., Jiao, K., Yan, Y., Yang, Y., Jiang, X., Li, C., et al. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.153872 · Cited by 18
Adipose tissue–gut microbiome crosstalk in inflammation and thermogenesis
Mauney, E. E., Wibowo, M. C., Tseng, Y., & Kostic, A. D. (2024) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2024.10.004 · Cited by 18
Treating the Metabolic Syndrome by Fecal Transplantation—Current Status
Malnick, S. D. H., Fisher, D. L., Somin, M., & Neuman, M. G. (2021) · Biology · doi:10.3390/biology10050447 · Cited by 19
“In addition, hyperglycemia has been shown to increase the permeability of the intestinal barrier through an alteration in tight junction integrity via the transcriptional reprogramming of the GLUT2-dependent epithelial cell [41].”
BackgroundAnti-Hyperglycemic Agents in the Adjuvant Treatment of Sepsis: Improving Intestinal Barrier Function
Wang, Y., Li, J., Wang, D., Jin, K., Hui, J., & Xu, H. (2022) · Drug Design Development and Therapy · doi:10.2147/dddt.s360348 · Cited by 18
Singla, S., Kumar, V., & Jena, G. (2023) · Biochimie · doi:10.1016/j.biochi.2023.03.009 · Cited by 18
Wu, Q., Zhao, M. F., Li, D., He, X., & Zang, W. (2023) · The FASEB Journal · doi:10.1096/fj.202202108r · Cited by 19
Kaempferol protects gut-vascular barrier from high glucose-induced disorder via NF-κB pathway
Chu, T., Yu, R., Gu, Y., Wang, Y., Chang, H., Li, Y., Li, J., & Bian, Y. (2023) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2023.109496 · Cited by 20
Zheng, B., Wen, H., Zheng, B., Xiang, X., & Zhu, C. (2025) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5c06354 · Cited by 18
Ahmad, F., Karim, A., Khan, J., & Qaisar, R. (2023) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001445 · Cited by 17
Diabetes exacerbates inflammatory bowel disease in mice with diet-induced obesity
Francis, K. L., Alonge, K. M., Pacheco, M. C., HU, S. J. W., KRUTZSCH, C. A., Morton, G. J., Schwartz, M. W., & Scarlett, J. M. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i33.4991 · Cited by 17
“Previous work had suggested that diabetic hyperglycemia impairs intestinal barrier function and increases intestinal permeability, although how this might impact IBD pathology had not been studied[25].”
InfluentialResearch trends of next generation probiotics
Hasnain, M. A., Kang, D., & Moon, G. (2024) · Food Science and Biotechnology · doi:10.1007/s10068-024-01626-9 · Cited by 17
Epithelial barrier theory in the context of nutrition and environmental exposure in athletes
Kistler, W., Villiger, M., Villiger, B., Yazıcı, D., Pat, Y., Mitamura, Y., Ardıçlı, S., Skolnick, S., Dhir, R., Akdiş, M., et al. (2024) · Allergy · doi:10.1111/all.16221 · Cited by 17
“77 Preservatives and artificial nutritional additives have been added to these products, 78 with limited studies on their impact on the epithelial barrier (Figure 4).”
Jatana, S., Abbadi, A., West, G. A., Ponti, A. K., Neto, M. B. B., Smith, J. L., Marino‐Melendez, A., Willard, B. B., Nagy, L. E., & de la Motte, C. (2024) · Matrix Biology · doi:10.1016/j.matbio.2024.08.007 · Cited by 19
Anand, S., & Patel, T. (2024) · Discover Oncology · doi:10.1007/s12672-024-01662-1 · Cited by 21
Global, regional, and national incidence and mortality for enteric infections from 1990 to 2019
Wang, B., Chen, D., Chen, H., Wu, W., Cheng, K., Tao, Y., Zhang, L., Liu, C., Ou, D., Zhang, M., et al. (2025) · BMC Public Health · doi:10.1186/s12889-024-21270-6 · Cited by 17
McDonnell, M., Harris, R. J., Borca, F., Mills, T., Downey, L., Dharmasiri, S., Patel, M. A., Zaré, B., Stammers, M., Smith, T. R., et al. (2020) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2020-000532 · Cited by 18
“Hyperglycaemia has also been 267 mechanistically linked to intestinal barrier dysfunction in both murine models and non-IBD human subjects.(15) 268 Through this mechanism, it is at least theoretically possible to link hyperglycaemia directly to intestinal 269 inflammation and IBD outcomes.”
BackgroundGao, H., Jin, Z., Tang, K., Ji, Y., Suárez, J., Suárez, J., Rocha, K. C. E., Zhang, D., DILLMANN, W. H., Mahata, S. K., et al. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.024561 · Cited by 19
“17 Thus, to assess whether intestinal mEVs were translocated from gut lumen into host adrenal glands, gut mEVs were collected from the small intestinal lumen of 16 weeks HFD-fed WT mice and labeled with PKH26 red fluorescent dye (Figure S1C through S1F).”
Zhang, B., Jin, Z., Zhai, T., Ding, Q., Yang, H., Wang, J., Zhang, L., & Zhao, L. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1011050 · Cited by 19
“In 2018, a research team pointed out hyperglycemia could drive intestinal barrier permeability through GLUT2-dependent transcriptional reprogramming of intestinal epithelial cells and alteration of tight and adherence junction integrity (Thaiss et al., 2018).”
BackgroundIncreased intestinal-fatty acid binding protein in obesity-associated type 2 diabetes mellitus
Tahapary, D. L., Fatya, A. I., Kurniawan, F., Marcella, C., Rinaldi, I., Tarigan, T. J. E., Harbuwono, D. S., Yunir, E., Soewondo, P., & Purnamasari, D. (2023) · PLoS ONE · doi:10.1371/journal.pone.0279915 · Cited by 17
“Another interesting view is that long-standing hyperglycemia leads to disrupted gut epithelial integrity [28].”
BackgroundmiR‐10b‐5p rescues leaky gut linked with gastrointestinal dysmotility and diabetes
Zogg, H., Singh, R., Ha, S. E., Wang, Z., Jin, B., Ha, M., Dafinone, M. E., Batalon, T., Hoberg, N., Poudrier, S. M., et al. (2023) · United European Gastroenterology Journal · doi:10.1002/ueg2.12463 · Cited by 17
Zhang, Z., He, X., Sun, Y., Li, J., & Sun, J. (2025) · Aging and Disease · doi:10.14336/ad.2025.0233 · Cited by 35
“Meanwhile, chronic hyperglycemia activates nuclear factor kappa B(NF-κB ) pathway, driving pro-inflammatory cytokine release and barrier dysfunction [91].”
Zheng, X., Cao, Z., Wang, M., Yuan, R., Han, Y., Li, A., & Wang, X. (2025) · Nutrients · doi:10.3390/nu17132052 · Cited by 17
“Studies have demonstrated that IEB dysfunction is linked to a wide spectrum of pathologies, encompassing gastrointestinal diseases, neurological disorders, allergic reactions, and metabolic dysfunction [2–5].”
Quo vadis? Central Rules of Pathogen and Disease Tropism
McCall, L. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.640987 · Cited by 17
Hyperglycemia and prematurity: a narrative review
Angelis, D., Jaleel, M. A., & Brion, L. P. (2023) · Pediatric Research · doi:10.1038/s41390-023-02628-9 · Cited by 22
“Furthermore, hyperglycemia increases the risk of bacterial intestinal translocation through GLUT2-mediated changes in gut epithelial cells, which results in loss of tight junction integrity.(67) The effects of hyperglycemia with a focus on newborn physiology are derived from preclinical data mainly on neuronal surviva…”
BackgroundKim, W. J., Kil, B. J., Lee, C., Kim, T. Y., Han, G., Choi, Y., Kim, K., Shin, C. H., Park, S.-Y., Kim, H., et al. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2319889 · Cited by 17
Endogenous Ethanol Production in the Human Alimentary Tract: A Literature Review
Stamation, R. (2025) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16869 · Cited by 17
“Crabtree-positive yeasts perhaps obtain an evolutionary advantage in high glucose en-virons, with their ethanol production suppressing the growth of other organisms [31, 32].”
Postprandial consequences of lipid absorption in the onset of obesity: Role of intestinal CD36
Lebrun, L. J., Milheiro, S. M., Tavernier, A., & Niot, I. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2022.159154 · Cited by 18
Zhou, J., Hou, P., Yao, Y., Yue, J., Zhang, Q., Yi, L., & Mi, M. (2022) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202101093 · Cited by 17
Zhang, X., Kang, Y., Jiang, C., Li, R., Xie, J., Jin, Y., Mei, X., Li, Y.-J., Liu, G., & Wang, Z.-G. (2018) · Molecules · doi:10.3390/molecules23102701 · Cited by 16
“The integrity of tight junctions and adhesive junctions between the intestinal epithelial cells will increase the permeability of the intestinal barrier, which will eventually lead to more enterotoxins such as lipopolysaccharide entering the circulatory system [29].”
BackgroundAntibiotic resistance, the 3As and the road ahead
Antão, E.-M., Vincze, S., Hanke, R., Klimmek, L., Suchecka, K., Lübke‐Becker, A., & Wieler, L. H. (2018) · Gut Pathogens · doi:10.1186/s13099-018-0280-7 · Cited by 16
Bouhlel, W., Kui, J., Bibette, J., & Brémond, N. (2022) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.1c01486 · Cited by 18
Fueling the fire: colonocyte metabolism and its effect on the colonic epithelia
Martínez-Ruiz, M., Robeson, M. S., & Piccolo, B. D. (2025) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2025.2507701 · Cited by 20
“In addition, intestinal-specific knock-down of the bidirectional GLUT2 transporter prevents STZ-induced barrier instability (Thaiss et al. 2018), further suggesting that glucose uptake and glycolytic metabolism by colonocytes weaken barrier function and increase gut permeability.”
Endotoxin’s Impact on Organism: From Immune Activation to Tolerance and Beyond
Roszak, K., Roy, K., Sobocińska, J., Spisz, P., Jędrzejewski, T., & Wrotek, S. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14186478 · Cited by 16
Tao, Y., Zhang, N., Wang, Z., Pan, Y., Zhong, S., & Liu, H. (2025) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd12120471 · Cited by 18
Apple-shaped obesity: A risky soil for cytokine-accelerated severity in COVID-19
Hosoya, T., Oba, S., Komiya, Y., Kawata, D., Kamiya, M., Iwai, H., Miyamoto, S., Kataoka, M., Tobiume, M., Kanno, T., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2300155120 · Cited by 16
“Ob/ob mice and db/ db mice are considered similarly immunocompromised (30–32), except for the report demonstrating greater sensitivity to endotoxin in ob/ob mice (33).”
Western diet components that increase intestinal permeability with implications on health
Jaquez-Durán, G., & Arellano-Ortiz, A. L. (2023) · International Journal for Vitamin and Nutrition Research · doi:10.1024/0300-9831/a000801 · Cited by 18
“…has been reported that hyperglycemia causes retrograde transport into the enterocytes through GLUT-2 and reprogramming in the epithelial transcriptome, with a decrease in the expression of genes involved in the glycosylation of proteins responsible for cell stability, including TJ proteins [ 33 ].”
BackgroundA glucose-supplemented diet enhances gut barrier integrity in Drosophila
Galenza, A., & Foley, E. (2021) · Biology Open · doi:10.1242/bio.056515 · Cited by 19
“…induced by streptozotocin treatment, drives intestinal barrier dysfunction by global transcriptional reprogramming of intestinal epithelial cells, including downregulation of N-glycan biosynthesis genes (Thaiss et al., 2018), a critical pathway for tight junction assembly (Nita-Lazar et al., 2010).”
Ge, H., Zhao, J., Zhang, S., Xu, Y., Liu, Y., Peng, X., Wang, G., Gong, X.-Y., Zhang, L., Li, S., et al. (2022) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2022.03.038 · Cited by 15
Host-microbe interactions at barrier tissues and immunomodulation: a scoping review
Chigozie, V. U., Enyi, E. O., Akwari, A. A., & Esimone, C. O. (2025) · Discover Bacteria. · doi:10.1007/s44351-025-00037-3 · Cited by 14
Liang, Z., He, Y., Wei, D., Fu, P., Li, Y., Wang, H., Yang, D., & Hou, X. (2024) · Food Science & Nutrition · doi:10.1002/fsn3.4108 · Cited by 14
Baba, B., Ceylani, T., Gurbanov, R., Açıkgöz, E., Keskin, S., Allahverdi, H., Samgane, G., Tombuloğlu, H., & Teker, H. T. (2024) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2024.105517 · Cited by 18
Improvement of Theaflavins on Glucose and Lipid Metabolism in Diabetes Mellitus
Xu, S., Chen, Y., & Gong, Y. (2024) · Foods · doi:10.3390/foods13111763 · Cited by 18
Peng, F., Yu, Z., Du, B., Niu, K., Xi, Y., Wang, S., & Yang, Y. (2025) · Food Research International · doi:10.1016/j.foodres.2024.115638 · Cited by 16
Du, J., Wang, Z., Diao, X., Liu, Q., Ma, W., & Liu, G. (2025) · Food Research International · doi:10.1016/j.foodres.2025.116636 · Cited by 14
Piccolo, B. D., Graham, J. L., Kang, P., Randolph, C. E., Shankar, K., Yeruva, L., Fox, R., Robeson, M. S., Moody, B., LeRoith, T., et al. (2021) · Physiological Reports · doi:10.14814/phy2.15102 · Cited by 17
Global Effect of COVID-19 Pandemic on Cancer Patients and its Treatment: A Systematic Review
Ali, M., Wani, S. U. D., Masoodi, M. H., Khan, N. A., Shivakumar, H. G., Osmani, R. A. M., & Khan, K. A. (2022) · Clinical Complementary Medicine and Pharmacology · doi:10.1016/j.ccmp.2022.100041 · Cited by 14
Ondee, T., Pongpirul, K., Udompornpitak, K., Sukkummee, W., Lertmongkolaksorn, T., Senaprom, S., & Leelahavanichkul, A. (2023) · Nutrients · doi:10.3390/nu15061462 · Cited by 14
“Although it is the main carbohydrate absorption site in the small intestine, hyperglycemia can induce enterocyte injury in all parts of the intestines, as it is one of the leading causes of intestinal integrity damage [88].”
BackgroundDeKruyff, R. H., Zhang, W., Nadeau, K. C., Leung, D. Y. M., & Wills-Karp, M. A. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.11.048 · Cited by 15
Lau, T. C., Fiebig‐Comyn, A., Shaler, C. R., McPhee, J. B., Coombes, B. K., & Schertzer, J. D. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00134.2021 · Cited by 14
“We first confirmed that diet-induced obesity 195 worsens blood glucose control because elevated blood glucose can degrade gut barrier function 196 and worsen outcomes from enteric infection in mice (55).”
BackgroundPadakandla, S. R., Das, T., Prashanthi, G. S., Angadi, K. K., Reddy, S. S., Reddy, G. B., & Shivaji, S. (2021) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.62.10.31 · Cited by 14
“Dysfunction of the intestinal barrier, leading to enhanced permeability and translocation of microbial molecules into the systemic circulation, has been implicated in DM 56,57 obesity and hyperglycemia and increased risk of systemic infection.”
Li, Y., Thelen, K. M., Fernández, K. M., Nelli, R. K., Fardisi, M., Rajput, M., Trottier, N. L., Contreras, G. A., & Moeser, A. J. (2022) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00207.2021 · Cited by 16
Metabolism of inositol derivatives by the gut microbiome
Jessen, H. J., & Bui, T. P. N. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2564765 · Cited by 15
“107 The health benefits of dietary phytate are likely to be partly mediated by SCFA formation through microbial conversion.”
Sun, Q., Iniguez, A. B., Tian, Q., Du, ., & Zhu, M. J. (2022) · Journal of Functional Foods · doi:10.1016/j.jff.2022.105291 · Cited by 13
Mikrani, R., Styles, I. K., Hoang, T. A., Abdallah, M., Senyschyn, D., Porter, C. J. H., Cao, E., & Trevaskis, N. L. (2022) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2022.10.019 · Cited by 14
Bishehsari, F., Drees, M., Adnan, D., Sharma, D., Green, S. J., Koshy, J., Giron, L. B., Goldman, A. R., Abdel‐Mohsen, M., Rasmussen, H. E., et al. (2023) · PROTEOMICS · doi:10.1002/pmic.202300023 · Cited by 15
“Reduced mucus generation in rodent models of high fat induced MetS could further affect the intestinal barrier and the insulin resistance [231, 232].”
Diabetes-Associated Breast Cancer Is Molecularly Distinct and Shows DNA Repair Deficiency
Panigrahi, G., Candia, J., Dorsey, T. H., Tang, W., Ohara, Y., Byun, J. S., Minas, T. Z., Zhang, A., Ajao, A., Cellini, A., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.170105 · Cited by 14
“Other observations show that diabetes and hyperglycemia alter the human gut microbiome and induce intestinal barrier dysfunction and enhance the risk for infections (15).”
BackgroundWang, S., Li, D., Li, G., Duan, N., He, C., Meng, J., Cheng, Y., Geng, X., Hou, L., Chang, M., et al. (2024) · Foods · doi:10.3390/foods13132148 · Cited by 13
“Contributions: S.W.: conceptualization, methodology, investigation, writing—review and writing—original”
BackgroundHuang, H., Liu, S., Peng, Z. W., Wang, B., Zhan, S., Huang, S., Li, W., Liu, D., Yang, X., Zhu, Y. Z., et al. (2025) · Food & Function · doi:10.1039/d4fo04446k · Cited by 14
Jiang, T., Du, P., Liu, D., Chen, H., Ma, Y., Hu, B., Li, J., Jiang, H., & Li, X. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1520439 · Cited by 15
“Hyperglycemia will increase intestinal permeability and destroy the intestinal mucosal barrier, and the dysfunction of the intestinal barrier will promote the absorption of pathogens and toxins, thus triggering the abnormal immune system (Yao et al., 2017; Thaiss et al., 2018).”
Intravital imaging of translocated bacteria via fluorogenic labeling of gut microbiota in situ
Fan, X., Zhou, Y., Bai, W., Li, X., Lin, L., Lin, H., Yang, M., Yu, X., Wang, J., Lin, L., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2415845122 · Cited by 16
“Obesity is widely considered to be closely associated with dysfunctional gut - vascular barriers, the so - called “leaky gut,” which can increase the risk of bacterial translocation, inflammation, and infection in obese or diabetic patients (8, 33, 34).”
Huang, Y., Liu, H., Mao, Q., Cong, X., Zhang, Y., Lee, S., Park, K., Wu, L., Xiang, R., & Yu, G. (2021) · Cells · doi:10.3390/cells10113230 · Cited by 13
“Obese and diabetic mice model ob/ob mice display enhanced intestinal permeability by reducing ZO-1 and occludin expression, which participates in the occurrence of intestinal disorders [35].”
BackgroundInfluentialZhang, X., Cui, X., Jin, X., Han, F., Wang, J., Yang, X., Xu, J., Shan, C., Gao, Z., Li, X., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00300 · Cited by 13
Zhao, Q., Shi, J., Chen, S., Hao, D., Wan, S., Niu, H., & Zhang, Y. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s372192 · Cited by 13
“Hyperglycemia directly drives intestinal barrier permeability through Glut2dependent reprogramming of intestinal epithelial cells, leading to intestinal barrier dysfunction and risk of intestinal infection.(16) Patients with T2DM are characterized by moderate intestinal microbe dysfunction, decreased abundance of some…”
BackgroundLiu, Y., Yu, G., Medsker, H., Luo, T., Meng, X., Wang, C., Feng, L., & Zhang, J. (2024) · Environmental Research · doi:10.1016/j.envres.2024.119442 · Cited by 12
Xiao, Y., Duan, J., Tan, C., Zou, J., Chen, S., Liu, T., Zhang, L. N., Chen, X., Xu, Y., Li, Y., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-76261-9 · Cited by 12
“If this barrier function is impaired for any reason, the risk of infection by colonizing bacteria in the gut will significantly increase 36,37 .”
BackgroundParantainen, J., Barreto, G., Strandberg, T. E., Mars, N., Nurmi, K., & Eklund, K. K. (2025) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2025.119220 · Cited by 13
Li, F., Luo, Q., Guo, T., Zhou, S., Cheng, Z., Pan, H., & Tu, J. (2025) · Annals of Medicine · doi:10.1080/07853890.2025.2561789 · Cited by 17
“…shown to impair intestinal barrier integrity through mechanisms, such as TLR4-mediated colonic inflammation [118], glucose transporter 2 (GLUT2)-mediated retrograde uptake of glucose into epithelial cells resulting in increased N-glycan biosynthesis [119], or downregulation of TJPs [117,120–122].”
Zhang, J., Tu, M., Liu, Z., & Zhang, G. (2020) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2020.102180 · Cited by 13
“Besides diet-induced obesity, previous studies have also shown that genetically obese (db/db) mice had reduced expression of tight-junction protein in the colon, enhanced gut leakage (as assessed by using FITC-dextran- and Citrobacter rodentium-based permeability assays), and higher concentrations of microbial pattern…”
BackgroundResultKimono, D. A. (2021) · Military Medical Research · doi:10.1186/s40779-021-00341-4 · Cited by 14
Mattavelli, E., Catapano, A. L., & Baragetti, A. (2021) · Nutrients · doi:10.3390/nu13113768 · Cited by 15
“For example, an elevated intestinal absorption of sugars promotes systemic inflammation by directly disrupting the intestinal barrier [26].”
BackgroundCell-Matrix Interactions Contribute to Barrier Function in Human Colon Organoids
Varani, J., McClintock, S. D., & Aslam, M. N. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.838975 · Cited by 13
“Barrier defects have also been seen in obesity related to high-fat and high-sugar diets (9, 10) and, thus, may contribute to chronic, systemic inflammation.”
BackgroundIs type 2 diabetes mellitus another intercellular junction-related disorder?
Collares‐Buzato, C. B., & Carvalho, C. P. D. F. (2022) · Experimental Biology and Medicine · doi:10.1177/15353702221090464 · Cited by 12
Erçin, M., Gezginci-Oktayoğlu, S., & Bolkent, Ş. (2022) · Translational research · doi:10.1016/j.trsl.2022.03.012 · Cited by 12
Diabetes-related perturbations in the integrity of physiologic barriers
Mooradian, A. D. (2023) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2023.108552 · Cited by 12
Ebrahim, A. S., Carion, T. W., Ebrahim, T., Win, P. H., Kani, H., Wang, Y., Stambersky, A., Ibrahim, A. S., Sosne, G., & Berger, E. A. (2023) · Biosensors · doi:10.3390/bios13110974 · Cited by 14
“These data coincide with previous findings that HG conditions reduce the barrier integrity of corneal epithelial cells [15], retinal pigment epithelial cells [45], and intestinal epithelial cells [45,46].”
ResultLv, H., Zhang, Z., Fu, B., Li, Z., Yin, T., Liu, C., Xu, B., Wang, D., Li, B., Hao, J., et al. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1296554 · Cited by 12
“Coupled with these patients ’ history of alcohol consumption, signi fi cant hyperglycemia, and systemic in fl ammation, these factors likely facilitate bacterial translocation from the gut to the bloodstream (Leclercq et al., 2014; Li et al., 2016; Thaiss et al., 2018).”
BackgroundLi, J., Zhang, M., Zhang, Z.-D., Pan, X., Pan, L., & Sun, J. T. (2024) · Acta Pharmacologica Sinica · doi:10.1038/s41401-024-01242-7 · Cited by 13
“Previous studies have shown that early-onset T1D patients, NOD mice and STZ-treated mice exhibit increased intestinal in fl ammation and compromised gut barrier integrity [36, 37].”
Han, C., Geng, Q., Qin, J., Li, Y., & Yu, H. (2022) · American Journal Of Pathology · doi:10.1016/j.ajpath.2022.03.002 · Cited by 14
Coleman, M. J., Espino, L. M., Lebensohn, H., Zimkute, M. V., Yaghooti, N., Ling, C. L., Gross, J., Listwan, N., Cano, S., Garcia, V., et al. (2022) · Metabolites · doi:10.3390/metabo12050431 · Cited by 13
Investigating the Association Between Diet-Induced “Leaky Gut” and the Development of Prediabetes
Dimba, N. R., Mzimela, N., Mosili, P., Ngubane, P. S., & Khathi, A. (2023) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-2181-6664 · Cited by 13
“The intestinal mucosal barrier and enterocytes provide the first line of defense in the gastrointestinal tract by preventing the translocation of luminal antigen, peptidoglycan, endotoxin LPS, and other foreign substances into the circulation [21, 22].”
BackgroundResultDietary L-arabinose-induced gut dysbiosis exacerbates Salmonella infection outcome
Yu, J., Tang, H., Zhou, N., Wang, Z., Huang, W., Chen, Y., Wang, D., Ni, J., Lu, J. L., & Yao, Y. (2024) · mSystems · doi:10.1128/msystems.00522-24 · Cited by 13
“Since L-arabinose is a dietary supplement for diabetic patients, who are usually associated with enteric infections and microbiota dysbiosis (23), it is urgent to clarify the role of L-arabinose in enteric infections.”
Background
Metadata
- Authors
- Thaiss, C. A., Levy, M., Grosheva, I., Zheng, D., Soffer, E., Blacher, E., Braverman, S., Tengeler, A. C., Barak, O., Elazar, M., Ben-Zeev, R., Lehavi-Regev, D., Katz, M. N., Pevsner-Fischer, M., Gertler, A., Halpern, Z., Harmelin, A., Aamar, S., Serradas, P., Grosfeld, A., Shapiro, H., Geiger, B., & Elinav, E.
- Affiliations
- Weizmann Institute of Science (IL)
- Hebrew University of Jerusalem (IL)
- Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.
- Tel Aviv Sourasky Medical Center (IL)
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Elinav, Eran
- ORCID
- Venue
- Science
- Published
- 2018-03-23
- Volume
- 359
- Issue
- 6382
- Pages
- 1376-1383
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2794419196
- Cited by
- 942
- References
- 56
- Citations by year
- 2026: 91 · 2025: 134 · 2024: 129 · 2023: 102 · 2022: 142 · 2021: 126 · 2020: 102 · 2019: 74 · 2018: 38
- FWCI
- 30.08
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Science (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- Bill & Melinda Gates Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Keywords
- hyperglycemia, intestinal barrier dysfunction, gastrointestinal infections, obesity, diabetes mellitus, GLUT2, intestinal epithelial cells, tight junctions, adherens junctions, intestinal permeability, microbial translocation, HbA1c, glycemic control, gut microbiota, systemic inflammation
- MeSH terms
- Gastrointestinal Microbiome, Animals, Blood Glucose, Diabetes Mellitus, Experimental, Escherichia coli Infections, Glucose, Humans, Hyperglycemia, Intestinal Diseases, Intestinal Mucosa, Mice, Inbred Strains, Obesity, Permeability, Streptozocin, Gene Deletion, Caco-2 Cells, Citrobacter rodentium, Glucose Transporter Type 2, Mice, Enteropathogenic Escherichia coli, Receptors, Leptin, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.